Latest News

Exclusive Interviews

Browse by Company

  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mydecine
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
All
  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mydecine
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
BetterLife Pharma News
Press Release

BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs

Mindset Pharma Press Release
Press Release

Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds

Numinus Company Profile
Press Release

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC

Delix Therapeutics PR
Press Release

Delix Therapeutics Co-Founder Publishes Groundbreaking Study Demonstrating Therapeutic Potential for a Psychedelic Analog—Without Hallucinogenic Effects

Silo Pharma Press Release
Press Release

Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter into Joint Venture Agreement to focus on the development of ketamine using ZTI’s Z-pod™ technology for the transdermal time released delivery of therapeutics

Pharmadrug Press Release
Press Release

PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation

Compass Pathways Press release
Press Release

COMPASS Pathways launches proposed public offering

Lobe Sciences PR
Press Release

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use